Indaptus Therapeutics, Inc. (INDP) Wednesday said that its Board has approved a one-for-twenty eight reverse stock split effective June 26, 2025.
The action is to regain compliance with the continued listing requirements of Nasdaq.
For comments and feedback: editorial@rttnews.com